(260 days)
The device is intended to remove organic and inorganic substances and microbial contaminants from water that is used to dilute dialysis concentrate to form dialysate, and to produce purified water for dialyzer reprocessing, and equipment rinse and disinfection.
The Biopure Series RO systems purify feed water through reverse osmosis a membrane separation process. In reverse osmosis, pressure is applied to force water through a semipermeable membrane, while leaving impurities on the feed side of the membrane. The membrane allows the solvent (water) to pass through but retains a large percentage of impurities such as dissolved inorganics, organics, bacteria, and pyrogens. The water that passes through the membrane (permeate), has significantly less contamination than the feed water. while the reject stream, which remains upstream of the membrane, has a much higher concentration than the feed stream.
The purpose of a pretreatment to reverse osmosis is to remove chlorinel chloramines and condition the feed water supplying the RO machine. The pretreatment section may include feed water boost pumps, a temperature blend valve, chemical feed unit, sediment/carbon cartridge filters, water softeners, multi media filters, carbon filters and dealkalizers.
The RO unit removes more than 99% of all micro-organisms, pyrogens, particles, and organics with a molecular weight greater than 300, and up to 95% of all dissolved inorganics. The elements of an RO unit include a prefilter, RO pressure pump, and RO membranes.
The purpose of a product water distribution system is to deliver water that meets or exceeds AAMI/ASAIO standards for water treatment equipment and water quality requirements for hemodialysis point of use. Additional product water treatment is intended to control or eliminate bacteria prior to point of use. The product water treatment system may include a storage tank, distribution pump, a distribution loop, UV disinfection, and hot water sanitization.
Depending on the series and model, Biopure water purification systems produce from 300 GPD (gallons per day) to 100 GPM (gallons per minute) at 75% recovery rate. Rejection of total dissolved solids and monovalent ions is in the range of 95%-99% depending on feed water characteristics. Colloids, bacteria, and organics larger than a 200 molecular weight are rejected at greater than 99%.
Biopure water purification systems product water that meets the requirements of ANSI / AAMI RD5-1992, Hemodialysis Systems.
The provided text describes a 510(k) premarket notification for the Biopure Series RO systems, which are water purification systems for hemodialysis. The document focuses on establishing substantial equivalence to legally marketed predicate devices, rather than detailing a specific study to prove the device meets acceptance criteria through rigorous performance testing outlined in the input request.
Therefore, much of the requested information regarding study design, sample sizes, ground truth establishment, expert involvement, and statistical analysis is not present in the provided text. The document primarily focuses on regulatory approval based on technological similarity and intended use.
Here's a breakdown of the available information based on your request:
1. A table of acceptance criteria and the reported device performance
The document states that the Biopure water purification systems produce product water that "meets the requirements of ANSI / AAMI RD5-1992, Hemodialysis Systems." ANSI/AAMI RD5-1992 specifies water quality standards for hemodialysis. The text also includes performance claims relevant to these standards:
| Acceptance Criteria (from ANSI / AAMI RD5-1992) | Reported Device Performance |
|---|---|
| Removal of micro-organisms | >99% rejection |
| Removal of pyrogens | >99% rejection |
| Removal of particles | >99% rejection |
| Removal of organics (>300 molecular weight) | >99% rejection |
| Removal of dissolved inorganics | Up to 95% rejection (95%-99% depending on feed water characteristics) |
| Removal of monovalent ions | 95%-99% rejection (depending on feed water characteristics) |
| Removal of colloids | >99% rejection |
| Removal of organics (>200 molecular weight) | >99% rejection |
| Product water output (recovery rate) | 300 GPD to 100 GPM at 75% recovery rate (depending on series and model) |
Note: The document states that the product water meets these requirements, implying these are the acceptance criteria. However, it does not provide a specific study report detailing the results of performance tests against these criteria with specific data tables for each analyte. It provides general performance capabilities of the RO technology.
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
Not specified. The document does not describe a performance study with a distinct test set, sample size, or data provenance. The 510(k) submission is based on substantial equivalence to predicate devices, not on a new, dedicated clinical or performance study of the Biopure system's ability to meet the ANSI/AAMI RD5-1992 requirements.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable/Not specified. This type of information is typically relevant for studies involving human interpretation or subjective assessments (e.g., medical image analysis). For a water purification system, "ground truth" would be established by analytical testing methods adhering to relevant standards (e.g., chemical analysis for purity, microbiological assays for contamination). The document does not describe the methodology for establishing ground truth for any testing, if such testing was performed for this submission.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable/Not specified. Adjudication methods are used when multiple experts assess a case. This concept is not relevant to the type of device and regulatory submission described.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a water purification system, not a diagnostic or AI-assisted medical imaging device that would involve human readers or AI assistance.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a water purification system, not an algorithm or AI system. Its performance is inherent to its physical and chemical processes.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
Inferred to be analytical measurements against water quality standards. For a water purification system, the "ground truth" for its performance would be established by laboratory analysis of the treated water, measuring parameters like total dissolved solids, specific ion concentrations, bacterial counts, and pyrogen levels, all compared against the limits specified in ANSI/AAMI RD5-1992. However, the document does not detail the specific ground truth establishment methods used for the Biopure system in the context of this submission. It only states the system "meets the requirements."
8. The sample size for the training set
Not applicable/Not specified. This concept is relevant for machine learning algorithms. For a physical device like a water purification system, there is no "training set" in the computational sense. If manufacturing or calibration data were used, that is not described here.
9. How the ground truth for the training set was established
Not applicable/Not specified. As there is no training set mentioned, this question is not relevant.
{0}------------------------------------------------
4. 510 (k) Summary of Safety and Effectiveness
This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of the Safe Medical Device Act (SMDA) of 1990 and 21CFR 807.92
Applicant
Biolab Equipment Canada Limited 505 Iroquois Shore Road, Unit 14 Oakville, Ontario L6H 2R3 David Weatherill - President Tel: 905 844-2062 Fax: 905 844-0023
Prepared by
J.P. Consulting Jerry Ponikvar --
128 Grandview Avenue Thornhill, Ontario L3T 1H6 jponikvar@sympatico.ca E-Mail Telephone (905) 882-2068 (905) 333-0601 Fax
Jerry Ponikvar, will respond to any requests for additional information.
Device Name
Trade Names Biopure Portable RO System Biopure 4400 Series RO System Biopure 8400 Series RO System Biopure Water Purification Pretreatment Components Softeners Biopure Performa Softener
| Backwash Filters | Biopure Magnum Series Water Softener |
|---|---|
| Biopure Performa Filter | |
| Biopure Magnum Series Carbon Filter | |
| Biopure Magnum Series Multimedia Filter |
Service Deionization Biopure Service DI
Biopure Premium Grade Service Di BiopureCation Bed DI Biopure Anion Bed DI Biopure Auto DI
Organic Bed Service Carbon
Biopure Carbon Biopure Product Water Distribution Components
Biopure CIP System Biopure Hot Water Sanitization System
Common or Usual Names
Reverse Osmosis systems with pretreatment and product water distribution components
Classification Name
Water Purification System for Hemodialysis Regulatory Classification - Class II 21 CFR 876.5665 Product Code: 78 FIP
Biolab510KPremarketSubmittalA.doc
{1}------------------------------------------------
510(K)Premarket Notification
Intended Use
The device is intended to remove organic and inorganic substances and microbial contaminants from water that is used to dilute dialysis concentrate to form dialysate, and to produce purified water for dialyzer reprocessing, and equipment rinse and disinfection.
Device Description
The Biopure Series RO systems purify feed water through reverse osmosis a membrane separation process. In reverse osmosis, pressure is applied to force water through a semipermeable membrane, while leaving impurities on the feed side of the membrane. The membrane allows the solvent (water) to pass through but retains a large percentage of impurities such as dissolved inorganics, organics, bacteria, and pyrogens. The water that passes through the membrane (permeate), has significantly less contamination than the feed water. while the reject stream, which remains upstream of the membrane, has a much higher concentration than the feed stream.
The purpose of a pretreatment to reverse osmosis is to remove chlorinel chloramines and condition the feed water supplying the RO machine. The pretreatment section may include feed water boost pumps, a temperature blend valve, chemical feed unit, sediment/carbon cartridge filters, water softeners, multi media filters, carbon filters and dealkalizers.
The RO unit removes more than 99% of all micro-organisms, pyrogens, particles, and organics with a molecular weight greater than 300, and up to 95% of all dissolved inorganics. The elements of an RO unit include a prefilter, RO pressure pump, and RO membranes.
The purpose of a product water distribution system is to deliver water that meets or exceeds AAMI/ASAIO standards for water treatment equipment and water quality requirements for hemodialysis point of use. Additional product water treatment is intended to control or eliminate bacteria prior to point of use. The product water treatment system may include a storage tank, distribution pump, a distribution loop, UV disinfection, and hot water sanitization.
Depending on the series and model, Biopure water purification systems produce from 300 GPD (gallons per day) to 100 GPM (gallons per minute) at 75% recovery rate. Rejection of total dissolved solids and monovalent ions is in the range of 95%-99% depending on feed water characteristics. Colloids, bacteria, and organics larger than a 200 molecular weight are rejected at greater than 99%.
Biopure water purification systems product water that meets the requirements of ANSI / AAMI RD5-1992, Hemodialysis Systems.
Predicate Devices
The Biopure Series RO systems, pre-treatment components, and product water components are substantially equivalent to the following legally marketed devices: Zyzatech Series RO systems, K964539 US Filter Water Purification System, K980182 These devices use reverse osmosis technology to purify water for hemodialysis applications.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles three wavy lines or stripes, which are meant to represent the human form. The logo is in black and white.
OCT 2 1 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Biolab Equipment Canada, Ltd. c/o Mr. Jerry Ponikvar, P.Eng J. P. Consulting 128 Grandview Avenue Thornhill, Ontario CANADA L3T 1H6
Re: K030348
Trade/Device Name: Biopure Portable RO System Biopure 4400 Series RO System Biopure 8400 Series RO System Biopure Water Purification Pretreatment Components Biopure Product Water Distribution Components Regulation Number: 21 CFR §876.5665
Regulation Name: Water purification system for hemodialysis Regulatory Class: II Product Code: 78 FIP Dated: July 22, 2003 Received: July 23, 2003
Dear Mr. Ponikvar:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter:
| 8xx. Ixxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours.
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
Page 2
{4}------------------------------------------------
3. Statement of Indications for Use
Applicant: Biolab Equipment Canada Limited
Establishment Registration # 9710313
510 (k) Number (if Known): K030348
Device Name:
Biopure Portable RO System Biopure 4400 Series RO System Biopure 8400 Series RO System Biopure Water Purification Pretreatment System Components Biopure Product Water System Components
Classification Name:
Water Purification System for Hemodialysis Regulatory Classification - Class II 21 CFR 876.5665 Product Code: 78 FIP
Indications for Use:
The device is intended to remove organic and inorganic substances and microbial contaminants from water that is used to dilute dialysis concentrate to form dialysate and to produce purified water for dialyzer reprocessing, and equipment rinse and disinfection. Enclosed below is a chart indicating the physical differences of the different systems, areas of use, and patient population.
| System Model | Biopure Portable | Biopure 4400 | Biopure 8400 |
|---|---|---|---|
| Area of Use | Home or hospital use, this systems allows dialysis treatment to patients not near a clinic | Hospital or Dialysis Clinics | Large Dialysis Clinics |
| Patient Population | 1 to 3 | 3 to 50 | 65 to 600 |
| Physical Dimensions | 39" x 12.5" x 28" | 72"x24"x32" to72"x18"x144" | 76"x32"x122" to76"x44"x162" |
| Weight | 120 to 135 lbs | 220 to 1610 lbs | 1200 - 8000 lbs |
Prescription Use (Per 21 CFR 801.109)
Nancy C. Brogdon
(Division Sign-Off) (Division of Reproductive, Abdominal, and Radiological D 510(k) Number
BiolabS10KPremarketSubmittalB
§ 876.5665 Water purification system for hemodialysis.
(a)
Identification. A water purification system for hemodialysis is a device that is intended for use with a hemodialysis system and that is intended to remove organic and inorganic substances and microbial contaminants from water used to dilute dialysate concentrate to form dialysate. This generic type of device may include a water softener, sediment filter, carbon filter, and water distillation system.(b)
Classification. Class II (special controls). The device, when it is a water purification subsystem disinfectant, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.